Jianjun Li

1.4k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Jianjun Li is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jianjun Li has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 20 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Jianjun Li's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Jianjun Li is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Jianjun Li collaborates with scholars based in China and United States. Jianjun Li's co-authors include Houjie Liang, Ganfeng Xie, Zhenyu Ding, Jingtao Tong, Liang‐Liang Chen, Feng Pan, Lan Zou, Yanling Zhang, Jianfang Chen and Feng Pan and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Jianjun Li

30 papers receiving 1.1k citations

Hit Papers

Inhibition of NF-κB signaling unveils novel strategies to... 2024 2026 2025 2024 10 20 30 40 50

Peers

Jianjun Li
Parmanand Malvi United States
Venugopal Gunda United States
Min Kyung Ju South Korea
Parmanand Malvi United States
Jianjun Li
Citations per year, relative to Jianjun Li Jianjun Li (= 1×) peers Parmanand Malvi

Countries citing papers authored by Jianjun Li

Since Specialization
Citations

This map shows the geographic impact of Jianjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Li more than expected).

Fields of papers citing papers by Jianjun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Li. The network helps show where Jianjun Li may publish in the future.

Co-authorship network of co-authors of Jianjun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Li. A scholar is included among the top collaborators of Jianjun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Li. Jianjun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaotong, et al.. (2025). Protective effects of silymarin against diquat-induced hepatitis in layer by inhibiting oxidative stress and TLR4/MyD88/NF-κB signaling pathway. Food and Chemical Toxicology. 204. 115626–115626. 1 indexed citations
2.
Zhang, Chi, Yue Zhang, Yan Dong, et al.. (2024). Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation. Cell Death Discovery. 10(1). 41–41. 15 indexed citations
3.
Li, Yuanfang, Hailin Tang, Sicheng Wang, et al.. (2024). Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers. Drug Resistance Updates. 73. 101042–101042. 54 indexed citations breakdown →
4.
Xu, Xin, Ke Han, Fan Bai, et al.. (2023). MicroRNAs in spinal cord injury: A narrative review. Frontiers in Molecular Neuroscience. 16. 1099256–1099256. 18 indexed citations
5.
Chen, Jianfang, Fengjun Sun, Xiang Zhao, et al.. (2022). LncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with hnRNPK in colorectal cancer. Cell & Bioscience. 12(1). 120–120. 7 indexed citations
6.
Wu, Shuang, Jianfang Chen, Xiang Zhao, et al.. (2022). Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma. Biology Direct. 17(1). 19–19. 6 indexed citations
7.
Chen, Liang‐Liang, et al.. (2017). MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. British Journal of Cancer. 117(1). 78–88. 95 indexed citations
8.
Dai, Lei, et al.. (2017). MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer. World Journal of Surgical Oncology. 15(1). 11–11. 40 indexed citations
9.
Li, Jianjun, Yinghui Zhang, Xiuchao Wang, & Ruibo Zhao. (2017). microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A. Oncology Letters. 13(6). 5021–5027. 17 indexed citations
11.
Liang, Liang, Li Gao, Menglan Huang, et al.. (2017). Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data. Molecular Medicine Reports. 17(2). 2297–2312. 13 indexed citations
12.
Li, Jianjun, Jie Luo, Yihuan Luo, et al.. (2016). Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study. Cancer Cell International. 16(1). 76–76. 28 indexed citations
13.
Geng, Peiliang, Juanjuan Ou, Jianjun Li, et al.. (2015). Genetic Association Between NFKBIA -881A>G Polymorphism and Cancer Susceptibility. Medicine. 94(31). e1024–e1024. 4 indexed citations
14.
Li, Jianjun, Hongyu Li, & Fei Gu. (2014). Diagnostic Significance of Serum Osteopontin Level for Pancreatic Cancer: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(8). 580–586. 19 indexed citations
15.
Chen, Jianfang, Zhenyu Ding, Feng Pan, et al.. (2014). HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein. PLoS ONE. 9(6). e98882–e98882. 138 indexed citations
16.
Xie, Ganfeng, et al.. (2014). Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo. Cell Biochemistry and Biophysics. 70(2). 1343–1350. 81 indexed citations
17.
Xiang, Lisha, Ganfeng Xie, Chen Liu, et al.. (2013). Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 2996–3005. 87 indexed citations
18.
Tong, Jingtao, et al.. (2011). Synergistic Antitumor Effect of Dichloroacetate in Combination with 5‐Fluorouracil in Colorectal Cancer. BioMed Research International. 2011(1). 740564–740564. 85 indexed citations
19.
Ding, Zhenyu, Yang Li, Xiaodong Xie, et al.. (2010). Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. Journal of Cancer Research and Clinical Oncology. 136(11). 1697–1707. 88 indexed citations
20.
Li, Jianjun, et al.. (2004). Activation of Nuclear Factor-κB and Correlation with Elevated Plasma C-reactive Protein in Patients with Unstable Angina. Heart Lung and Circulation. 13(2). 173–178. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026